310 related articles for article (PubMed ID: 33832905)
1. Binary inclusion complexes of diflunisal with β-cyclodextrin and hydroxypropyl-β-cyclodextrin: Preparation and characterization.
Bashir M; Syed HK; Asghar S; Irfan M; Aslam N; Iqbal MS; Khan IU; Shah PA; Khan NR; Ahmad J; Saleem M; Asif M
Pak J Pharm Sci; 2020 Sep; 33(5(Supplementary)):2307-2315. PubMed ID: 33832905
[TBL] [Abstract][Full Text] [Related]
2. Effect of Hydrophilic Polymers on Complexation Efficiency of Cyclodextrins in Enhancing Solubility and Release of Diflunisal.
Bashir M; Syed HK; Asghar S; Irfan M; Almalki WH; Menshawi SA; Khan IU; Shah PA; Khalid I; Ahmad J; Gohar UF; Peh KK; Iqbal MS
Polymers (Basel); 2020 Jul; 12(7):. PubMed ID: 32679660
[TBL] [Abstract][Full Text] [Related]
3. Enhanced Solubility and Stability of Aripiprazole in Binary and Ternary Inclusion Complexes Using Hydroxy Propyl Beta Cyclodextrin (HPβCD) and L-Arginine.
Awais S; Farooq N; Muhammad SA; El-Serehy HA; Ishtiaq F; Afridi M; Ahsan H; Ullah A; Nadeem T; Sultana K
Molecules; 2023 May; 28(9):. PubMed ID: 37175270
[TBL] [Abstract][Full Text] [Related]
4. Preparation and comparison of binary and ternary inclusion complexes of aripiprazole using L-arginine/lysine and MβCD/HPβCD by using different molar ratios.
Awais S; Afridi M; Batool A; Ansari MT; Sultana K; Momal H; Alsanie WF; S Alamri A; Alhomrani M
Pak J Pharm Sci; 2024 Jan; 37(1(Special)):245-255. PubMed ID: 38747276
[TBL] [Abstract][Full Text] [Related]
5. Effect of beta-cyclodextrin and hydroxypropyl beta-cyclodextrin complexation on physicochemical properties and antimicrobial activity of cefdinir.
Aleem O; Kuchekar B; Pore Y; Late S
J Pharm Biomed Anal; 2008 Jul; 47(3):535-40. PubMed ID: 18367363
[TBL] [Abstract][Full Text] [Related]
6. Diloxanide furoate binary complexes with β-, methyl-β-, and hydroxypropyl-β-cyclodextrins: inclusion mode, characterization in solution and in solid state and in vitro dissolution studies.
Aloisio C; Longhi M
Pharm Dev Technol; 2018 Sep; 23(7):723-731. PubMed ID: 28758845
[TBL] [Abstract][Full Text] [Related]
7. Comparative study of ibuproxam complexation with amorphous beta-cyclodextrin derivatives in solution and in the solid state.
Mura P; Zerrouk N; Faucci M; Maestrelli F; Chemtob C
Eur J Pharm Biopharm; 2002 Sep; 54(2):181-91. PubMed ID: 12191690
[TBL] [Abstract][Full Text] [Related]
8. Influence of hydroxypropyl-beta-cyclodextrin complexation on piroxicam release from buccoadhesive tablets.
Jug M; Bećirević-Laćan M
Eur J Pharm Sci; 2004 Feb; 21(2-3):251-60. PubMed ID: 14757497
[TBL] [Abstract][Full Text] [Related]
9. Original research paper. A superior preparation method for daidzein-hydroxypropyl-β-cyclodextrin complexes with improved solubility and dissolution: Supercritical fluid process.
Pan H; Wang HB; Yu YB; Cheng BC; Wang XY; Li Y
Acta Pharm; 2017 Mar; 67(1):85-97. PubMed ID: 28231046
[TBL] [Abstract][Full Text] [Related]
10. Influence of levodropropizine and hydroxypropyl-β-cyclodextrin association on the physicochemical characteristics of levodropropizine loaded in hydroxypropyl-β-cyclodextrin microcontainers: Formulation and in vitro characterization.
Yousaf AM; Qadeer A; Raza SA; Chohan TA; Shahzad Y; Din FU; Khan IU; Hussain T; Alvi MN; Mahmood T
Polim Med; 2019; 49(1):35-43. PubMed ID: 31769938
[TBL] [Abstract][Full Text] [Related]
11. Preparation and characterization of inclusion complexes of prazosin hydrochloride with beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin.
Liu L; Zhu S
J Pharm Biomed Anal; 2006 Jan; 40(1):122-7. PubMed ID: 16095859
[TBL] [Abstract][Full Text] [Related]
12. Inclusion complex and nanoclusters of cyclodextrin to increase the solubility and efficacy of albendazole.
Pacheco PA; Rodrigues LNC; Ferreira JFS; Gomes ACP; Veríssimo CJ; Louvandini H; Costa RLD; Katiki LM
Parasitol Res; 2018 Mar; 117(3):705-712. PubMed ID: 29327323
[TBL] [Abstract][Full Text] [Related]
13. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
Badr-Eldin SM; Elkheshen SA; Ghorab MM
Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
[TBL] [Abstract][Full Text] [Related]
14. Preparation, characterization, and antifungal property of the inclusion complex of Litsea cubeba essential oil/hydroxypropyl-β-cyclodextrin and its application in preservation of Shatang mandarin.
Li X; Li G; Shan Y; Zhu X
J Food Sci; 2022 Oct; 87(10):4714-4724. PubMed ID: 36121061
[TBL] [Abstract][Full Text] [Related]
15. Characterization of beta-lapachone and methylated beta-cyclodextrin solid-state systems.
Cunha-Filho MS; Dacunha-Marinho B; Torres-Labandeira JJ; Martínez-Pacheco R; Landín M
AAPS PharmSciTech; 2007 Jul; 8(3):E60. PubMed ID: 17915810
[TBL] [Abstract][Full Text] [Related]
16. Improvement in solubility and dissolution rate of 1, 2-dithiole-3-thiones upon complexation with beta-cyclodextrin and its hydroxypropyl and sulfobutyl ether-7 derivatives.
Dollo G; Le Corre P; Chollet M; Chevanne F; Bertault M; Burgot JL; Le Verge R
J Pharm Sci; 1999 Sep; 88(9):889-95. PubMed ID: 10479350
[TBL] [Abstract][Full Text] [Related]
17. Formulation of Apigenin-Cyclodextrin-Chitosan Ternary Complex: Physicochemical Characterization, In Vitro and In Vivo Studies.
Jafar M; Khalid MS; Alghamdi H; Amir M; Al Makki SA; Alotaibi OS; Al Rmais AA; Imam SS; Alshehri S; Gilani SJ
AAPS PharmSciTech; 2022 Feb; 23(2):71. PubMed ID: 35146576
[TBL] [Abstract][Full Text] [Related]
18. Improved Aqueous Solubility and Antihypercholesterolemic Activity of Ezetimibe on Formulating with Hydroxypropyl-β-Cyclodextrin and Hydrophilic Auxiliary Substances.
Srivalli KM; Mishra B
AAPS PharmSciTech; 2016 Apr; 17(2):272-83. PubMed ID: 26077622
[TBL] [Abstract][Full Text] [Related]
19. Characterization of an inclusion complex of cholesterol and hydroxypropyl-beta-cyclodextrin.
Williams RO; Mahaguna V; Sriwongjanya M
Eur J Pharm Biopharm; 1998 Nov; 46(3):355-60. PubMed ID: 9885309
[TBL] [Abstract][Full Text] [Related]
20. Physicochemical characterization of efavirenz-cyclodextrin inclusion complexes.
Sathigari S; Chadha G; Lee YH; Wright N; Parsons DL; Rangari VK; Fasina O; Babu RJ
AAPS PharmSciTech; 2009; 10(1):81-7. PubMed ID: 19148759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
